[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 22, Issue 1 (3-2020) ::
J Gorgan Univ Med Sci 2020, 22(1): 77-81 Back to browse issues page
Prevalence of acquired kidney cysts and its related factors in hemodialysis patients
Saeid Amirkhanlou * 1, Parnian Eghbalian2 , Anna Rashedi3 , Gholeamreza Roshandel4
1- Assistant Professor of Nephrology, Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran , drsam74ir@ymail.com
2- Medical Student, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
3- Assistant Professor of Radiology, Golestan University of Medical Sciences, Gorgan, Iran.
4- Epidemiologist, Associate Professor, Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Gorgan, Iran.
Abstract:   (9978 Views)
Background and Objective: Acquired kidney cysts usually occur in end stage renal disease (ESRD) patients undergoing long-term hemodialysis. Increasing growth of cysts is also seen in asymptomatic patients and they can cause complications such as retroperitoneal and intrarenal bleeding, Erythrocytosis, infection of cysts and renal cell carcinoma with distant metastases. This study was designed to evaluate the prevalence of acquired kidney cysts and its related factors in hemodialysis patients.
Methods: In this descriptive-analytical study, 123 patients (mean age 55.22+13.23 years) were selected from hemodialysis patients referred to dialysis center. Patients with autosomal polycystic kidney disease, medullary sponge kidney and medullary cystic kidney disease were not included. Diagnosis of acquired kidney cysts of Patients was performed by ultrasonography.
Results: The overall prevalence of kidney cysts was 44.6%. 30 percent of diabetic patients had kidney cysts, while kidney cysts were present in 51.2% of nondiabetic patients. 32.4% of patients were received twice a week dialysis and 42.4% of patients were received three times a week dialysis had kidney cysts. Mean±SD of duration of dialysis history in patients with cystic kidneys was 22.02±22.65 months, while these measures in patients with noncystic kidneys were 22.65±14.65 months. There was a relationship between kidney cysts and the numder of hemodialysis per week (P<0.05). There was a relationship between prevalence of kidney cysts and the qulity of hemodialysis (P<0.05)
Conclusion: This study showed that there was a relationship between prevalence of kidney cysts and the qulity of hemodialysis and the numder of hemodialysis per week.
Keywords: Hemodialysis, Kidney cysts, Iran
Article ID: Vol22-11
Full-Text [PDF 178 kb]   (14093 Downloads)    
Type of Study: Original Articles | Subject: Nephrology
References
1. Bindroo S, Challa HJ. Renal Failure. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2019.
2. Beard BH. Fear of death and fear of life. The dilemma in chronic renal failure, hemodialysis, and kidney transplantation. Arch Gen Psychiatry. 1969 Sep; 21(3): 373-80.
3. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008 Oct; 359(14): 1477-85. doi: 10.1056/NEJMcp0804458
4. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 1992 May; 19(5): 453-59.
5. Gnionsahe DA, Lagou DA, Tia WM. Prevalence of acquired cystic disease in black Africans on hemodialysis in West Africa. Saudi J Kidney Dis Transpl. 2007 Mar; 18(1): 114-16.
6. Hussain S, Khan SA, Dodhy KA, Khan FA. Sonographic prevalence of acquired cystic renal disease in patients receiving haemodialysis. J Pak Med Assoc. 2003 Mar; 53(3): 111-13.
7. Narasimhan N, Golper TA, Wolfson M, Rahatzad M, Bennett WM. Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int. 1986 Nov; 30(5): 748-52.
8. Beladi Mousavi SS, Sametzadeh M, Hayati F, Fatemi SM. Evaluation of Acquired Cystic Kidney Disease in Patients on Hemodialysis With Ultrasonography. Iran J Kidney Dis. 2010; 4(3): 223-26.
9. Bashardoost B, Adib A, Faaalpoor Z, Gavami Nashr M. [The Study of Hypertension Relationship with Weight Gain in Patients Hemodialysis Intervals]. J Ardabil Univ Med Sci. 2007; 7(1): 22-26. [Article in Persian]
10. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007 Apr; 369(9569): 1287-1301. doi: 10.1016/S0140-6736(07)60601-1
11. Harris PC, Torres VE. Polycystic Kidney Disease, Autosomal Dominant. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 2002 Jan 10 [updated 2018 Jul 19]
12. Rahbari-Oskoui F, O'Neill WC. Diagnosis and Management of Acquired Cystic Kidney Disease and Renal Tumors in ESRD Patients. Semin Dial. 2017 Jul; 30(4): 373-79. doi: 10.1111/sdi.12605
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amirkhanlou S, Eghbalian P, Rashedi A, Roshandel G. Prevalence of acquired kidney cysts and its related factors in hemodialysis patients. J Gorgan Univ Med Sci 2020; 22 (1) :77-81
URL: http://goums.ac.ir/journal/article-1-3558-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 1 (3-2020) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)